2-(Methylsulfonyl)phenylboronic acid

Product Information

Molecular Formula:
C7H9BO4S
Molecular Weight:
200.02
Description
2-(Methylsulfonyl)phenylboronic acid is mainly used in biomedical research as a reagent for drug development. In particular, it has wide application in the synthesis of drugs for the treatment of inflammation and certain cancers, helping to promote related drug innovation.
Synonyms
[2-(Methylsulfonyl)phenyl]boronic acid; 2-(METHYLSULPHONYL)PHENYLBORONIC ACID; 2-(Methylsulphonyl)benzeneboronic acid; 2-methylsulfonyl phenylboronic acid; 2-methylsulfonylphenyl boronic acid; (2-methanesulfonylphenyl)boronic acid; (2-(Methylsulfonyl)phenyl)boronicacid; (2-(methylsulfonyl)phenyl) boronic acid; 2-(METHYLSULFONYL)BENZENEBORONIC ACID; 2-(Methylsulfonyl)phenylboronic acid
IUPAC Name
(2-methylsulfonylphenyl)boronic acid
Canonical SMILES
B(C1=CC=CC=C1S(=O)(=O)C)(O)O
InChI
InChI=1S/C7H9BO4S/c1-13(11,12)7-5-3-2-4-6(7)8(9)10/h2-5,9-10H,1H3
InChI Key
MSQFFCRGQPVQRS-UHFFFAOYSA-N
Flash Point
Not applicable
Purity
98%

Safety Information

Hazards
H319
Precautionary Statement
P305 + P351 + P338

Computed Properties

Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
2
Exact Mass
200.0314601 g/mol
Monoisotopic Mass
200.0314601 g/mol
Topological Polar Surface Area
83Ų
Heavy Atom Count
13
Formal Charge
0
Complexity
256
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes

Patents

Publication Number Title Priority Date
WO-2022028598-A1 Atr inhibitors and uses thereof 2020-08-07
WO-2022008912-A1 Benzodiazepine derivatives useful in treating a respiratory syncytial virus infection 2020-07-07
CN-112159405-A Pyridopyrimidinone compounds and application thereof 2020-02-04
CN-112159405-B Pyridopyrimidinone compounds and application thereof 2020-02-04
WO-2021012049-A1 Substituted 2-morpholinopyridine derivatives as atr kinase inhibitors 2019-07-22
CA-3148278-A1 Substituted 2-morpholinopyridine derivatives as atr kinase inhibitors 2019-07-22
CN-114174292-A Substituted 2-morpholinopyridine derivatives as ATR kinase inhibitors 2019-07-22
WO-2020121261-A1 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same 2018-12-14
AU-2019398910-A1 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same 2018-12-14
BR-112021010341-A2 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same 2018-12-14
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Online Inquiry
  • Verification code
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All rights reserved.
Top
Inquiry Basket